Sign In
Buy CNCE
$8.37
+0 (+0%)
At Close: May 30, 2023
Concert Pharmaceuticals Announces Results from CTP-692 Phase 2 Trial in Patients with Schizophrenia
07:00am, Monday, 01'st Feb 2021
LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #CNCE--Concert announced its Phase 2 trial to evaluate CTP-692 as an adjunctive treatment in patients with schizophrenia did not meet the primary endpoint.
Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q3 2020 Results - Earnings Call Transcript
03:17am, Sunday, 08'th Nov 2020
Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q3 2020 Results - Earnings Call Transcript
LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #CNCE--Concert presented initial data from an ongoing long-term, open-label extension study of CTP-543 in patients with alopecia areata at EADV.
Peace hopes at stake as northern Cyprus voters go to the polls
08:01pm, Sunday, 11'th Oct 2020
Unofficial early results show first round voting has narrowed field to leftist incumbent and rightwing nationalist
Turkish Cypriots choose leader with peace deal at stake
04:45pm, Sunday, 11'th Oct 2020
Turkish Cypriots are voting for a leader tasked with overcoming deep political chasms with rival Greek Cypriots in order to pave the way for a deal to end 46 years of ethnic division in Cyprus and que
The Global Thermal Treatment Air Filtration Market will grow by $ 888.29 mn during 2020-2024
Concert Pharmaceuticals Inc (NASDAQ:CNCE) Shares Acquired by Steward Partners Investment Advisory LLC
07:25am, Saturday, 22'nd Aug 2020
Steward Partners Investment Advisory LLC boosted its holdings in Concert Pharmaceuticals Inc (NASDAQ:CNCE) by 8.5% in the 2nd quarter, according to the company in its most recent 13F filing with the S
Concert Pharmaceuticals to Present at The JMP Securities CNS Forum
10:00am, Tuesday, 18'th Aug 2020
Concert to participate in a fireside chat with Jason Butler at The JMP Securities CNS Forum.
How Does Concert Pharmaceuticals' (NASDAQ:CNCE) CEO Salary Compare to Peers?
12:06pm, Wednesday, 12'th Aug 2020
Roger Tung has been the CEO of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) since 2006, and this article will examine...
Concert Pharmaceuticals (CNCE) Reports Q2 Loss, Tops Revenue Estimates
03:05pm, Thursday, 06'th Aug 2020
Concert (CNCE) delivered earnings and revenue surprises of 39.71% and 63770.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Concert Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Company Update
11:00am, Thursday, 06'th Aug 2020
Concert will host a conference call and webcast today at 8:30 a.m. ET to provide an update on the Company and discuss second quarter 2020 results.
Concert Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Company Update
12:00am, Thursday, 06'th Aug 2020
Concert will host a conference call and webcast today at 8:30 a.m. ET to provide an update on the Company and discuss second quarter 2020 results.
Dupont Capital Management Corp Makes New $304,000 Investment in Concert Pharmaceuticals Inc (NASDAQ:CNCE)
06:24am, Wednesday, 05'th Aug 2020
Dupont Capital Management Corp purchased a new position in Concert Pharmaceuticals Inc (NASDAQ:CNCE) during the second quarter, HoldingsChannel reports. The institutional investor purchased 30,525 sha
Will Concert Pharmaceuticals (CNCE) Report Negative Q2 Earnings? What You Should Know
04:33pm, Thursday, 30'th Jul 2020
Concert (CNCE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Concert Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 6, 2020
11:00am, Thursday, 30'th Jul 2020
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its second quarter 2020 financial results on Thursday, August 6, 2020, before the U.S. financial markets open. The Comp
